OR WAIT null SECS
June 25, 2015
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
May 21, 2015
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
April 27, 2015
Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.
April 20, 2015
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
April 03, 2015
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
April 02, 2015
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
March 26, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
March 25, 2015
Emergent BioSolutions announced FDA approval of Anthrasil, an inhalable treatment that targets Anthrax toxins, as well as a contract with BARDA to develop NuThrax, an anthrax vaccine candidate.
March 24, 2015
The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.